ImageneBio (IMA) Consolidated Net Income (2020 - 2025)

ImageneBio has disclosed Consolidated Net Income across 6 years of filings, most recently posting -$24.8 million for Q3 2025.

• Consolidated Net Income for Q3 2025 came in at -$24.8 million, down 678.48% year-over-year; the trailing twelve-month figure through Dec 2025 was -$33.7 million (up 33.41% YoY), and the FY2024 annual result was -$49.2 million, up 27.77% from the prior year.
• Consolidated Net Income came in at -$24.8 million for Q3 2025 at ImageneBio, down from -$2.8 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $2.8 million in Q4 2021 to a low of -$24.8 million in Q3 2025.
• The 5-year median for Consolidated Net Income is -$14.5 million (2021), against an average of -$13.4 million.
• Across the five-year window, Consolidated Net Income surged 110.74% in 2021 and slumped 678.48% in 2025, its largest moves.
• ImageneBio's Consolidated Net Income stood at $2.8 million in 2021, then slumped by 604.0% to -$14.1 million in 2022, then sank by 39.4% to -$19.7 million in 2023, then climbed by 11.06% to -$17.5 million in 2024, then plunged by 41.77% to -$24.8 million in 2025.
• The last three Consolidated Net Income figures came in at -$24.8 million (Q3 2025), -$2.8 million (Q2 2025), and -$6.1 million (Q1 2025), per Business Quant data.